Skip to main content



Breast cancer is the leading malignancy and leading cause of cancer-related death in women globally. The greatest barrier to a treatment is the incomplete understanding of mechanisms underlying molecular regulators whose function is cellular adaptation to estrogen. One such enzyme, ATAD3A, a nuclear-encoded mitochondrial enzyme, has been brought under this lab’s scrutiny. The role of ATAD3A in breast cancer progression is largely unknown but it has been shown to be a crucial mediator in promoting cell cycle progression. The two objectives of this project were: to determine whether the ATAd3A is an Estrogen Receptor-α target (ERα) and to determine the role of (ERα) in estrogen induced ATAD3A upregulation. To test these objectives, four breast cancer cell lines, two or which were ERα+ and two were ERα- were used. ERα knockdown cells were achieved by small interfering RNA. All cell lines were treated to undergo induction of ER activation. Gene expression was determined by real time RT-PCR, western blots, and MTT assays. The results found were statistically significant and pave the way to future experiments.


File nameDate UploadedVisibilityFile size
19 Jul 2022
95.1 kB



  • Event location
    • Nesbitt 3110

  • Event date
    • 3 November 2018

  • Date submitted

    19 July 2022